Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules.

Quagliata L, Andreozzi M, Kovac M, Tornillo L, Makowska Z, Moretti F, Heim MH, Heinimann K, Piscuoglio S, Terracciano LM.

Eur J Cancer. 2014 Mar;50(4):731-8. doi: 10.1016/j.ejca.2013.11.018. Epub 2013 Dec 3.

PMID:
24315626
2.

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.

Gastroenterology. 2006 Dec;131(6):1758-67. Epub 2006 Sep 19.

PMID:
17087938
3.

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.

Salvi A, Abeni E, Portolani N, Barlati S, De Petro G.

Int J Oncol. 2013 Feb;42(2):391-402. doi: 10.3892/ijo.2012.1716. Epub 2012 Nov 28.

4.

Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.

Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.

Int J Oncol. 2005 Mar;26(3):661-71.

PMID:
15703821
5.

[MicroRNA profiling in patients with hepatocellular carcinoma].

Wang CX, Song W, Li ZJ, Song B, Wu DH, Sun AM, Chen LH.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 May;30(5):976-7. Chinese.

6.

Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.

Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M, Xiao J, Han T, Zhu Z, Wang T, Liu X, Lopez R, Frankel P, Jong A, Yen Y.

Am J Pathol. 2003 Jun;162(6):1961-74.

7.

Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.

Liu X, Wang SK, Zhang K, Zhang H, Pan Q, Liu Z, Pan H, Xue L, Yen Y, Chu PG.

Carcinogenesis. 2015 Feb;36(2):232-42. doi: 10.1093/carcin/bgu245. Epub 2014 Dec 25.

PMID:
25542894
8.

Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.

Shih YL, Hsieh CB, Yan MD, Tsao CM, Hsieh TY, Liu CH, Lin YW.

J Gastroenterol Hepatol. 2013 Mar;28(3):551-9. doi: 10.1111/jgh.12078.

PMID:
23215838
9.

Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.

Bureau C, PĂ©ron JM, Bouisson M, Danjoux M, Selves J, Bioulac-Sage P, Balabaud C, Torrisani J, Cordelier P, Buscail L, Vinel JP.

J Gastroenterol Hepatol. 2008 Jan;23(1):78-86. doi: 10.1111/j.1440-1746.2007.05234.x.

PMID:
18171345
10.

Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.

Ploeger C, Waldburger N, Fraas A, Goeppert B, Pusch S, Breuhahn K, Wang XW, Schirmacher P, Roessler S.

Hepatology. 2016 Sep;64(3):828-42. doi: 10.1002/hep.28684. Epub 2016 Jul 15.

11.

Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.

Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.

J Surg Oncol. 2012 Mar 15;105(4):381-6. doi: 10.1002/jso.22135. Epub 2011 Nov 3.

PMID:
22052684
13.

Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.

Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.

Cancer. 2006 Aug 1;107(3):579-90.

14.

[Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].

Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):831-6. Chinese.

PMID:
19173828
15.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
16.

Down-regulated expression of the TSAP6 protein in liver is associated with a transition from cirrhosis to hepatocellular carcinoma.

Caillot F, Daveau R, Daveau M, Lubrano J, Saint-Auret G, Hiron M, Goria O, Scotte M, Francois A, Salier JP.

Histopathology. 2009 Feb;54(3):319-27. doi: 10.1111/j.1365-2559.2009.03224.x.

PMID:
19236508
17.

Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.

Heringlake S, Hofdmann M, Fiebeler A, Manns MP, Schmiegel W, Tannapfel A.

J Hepatol. 2010 Feb;52(2):220-7. doi: 10.1016/j.jhep.2009.11.005. Epub 2009 Nov 25.

PMID:
20036025
18.

Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.

Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA.

Liver Transpl. 2004 May;10(5):607-20.

19.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
20.

p53 expression in patients with cirrhosis with and without hepatocellular carcinoma.

Livni N, Eid A, Ilan Y, Rivkind A, Rosenmann E, Blendis LM, Shouval D, Galun E.

Cancer. 1995 May 15;75(10):2420-6.

Supplemental Content

Support Center